Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
14 07 2020
Historique:
received: 18 11 2019
accepted: 17 05 2020
entrez: 25 6 2020
pubmed: 25 6 2020
medline: 13 5 2021
Statut: ppublish

Résumé

Microvascular thrombosis and blood-brain barrier (BBB) breakdown are key components of cerebral malaria (CM) pathogenesis in African children and are implicated in fatal brain swelling. How Plasmodium falciparum infection causes this endothelial disruption and why this occurs, particularly in the brain, is not fully understood. In this study, we have demonstrated that circulating extracellular histones, equally of host and parasite origin, are significantly elevated in CM patients. Higher histone levels are associated with brain swelling on magnetic resonance imaging. On postmortem brain sections of CM patients, we found that histones are colocalized with P falciparum-infected erythrocytes sequestered inside small blood vessels, suggesting that histones might be expelled locally during parasite schizont rupture. Histone staining on the luminal vascular surface colocalized with thrombosis and leakage, indicating a possible link between endothelial surface accumulation of histones and coagulation activation and BBB breakdown. Supporting this, patient sera or purified P falciparum histones caused disruption of barrier function and were toxic to cultured human brain endothelial cells, which were abrogated with antihistone antibody and nonanticoagulant heparin. Overall, our data support a role for histones of parasite and host origin in thrombosis, BBB breakdown, and brain swelling in CM, processes implicated in the causal pathway to death. Neutralizing histones with agents such as nonanticoagulant heparin warrant exploration to prevent brain swelling in the development or progression of CM and thereby to improve outcomes.

Identifiants

pubmed: 32579667
pii: S2473-9529(20)31611-6
doi: 10.1182/bloodadvances.2019001258
pmc: PMC7362376
doi:

Substances chimiques

Histones 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2851-2864

Subventions

Organisme : British Heart Foundation
ID : PG/14/19/30751
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 084679/Z/08/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/16/65/32313
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104111
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : P01 HL144457
Pays : United States
Organisme : Wellcome Trust
ID : 109698/Z/15/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI034969
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Br J Haematol. 2016 Dec;175(5):935-948
pubmed: 27549988
Am J Pathol. 2012 Mar;180(3):1028-1039
pubmed: 22260922
Nat Med. 2009 Nov;15(11):1318-21
pubmed: 19855397
Parasitology. 1997 May;114 ( Pt 5):413-9
pubmed: 9149412
Am J Pathol. 2018 Jan;188(1):135-148
pubmed: 29107075
Pancreatology. 2017 Nov - Dec;17(6):884-892
pubmed: 29102149
Trends Parasitol. 2017 Nov;33(11):832-835
pubmed: 28709836
J Cell Mol Med. 2018 Oct;22(10):4617-4629
pubmed: 30085397
Front Cell Infect Microbiol. 2015 Mar 16;5:18
pubmed: 25853095
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1772-81
pubmed: 22619330
Sci Rep. 2015 Jun 01;5:10425
pubmed: 26030010
Malar J. 2016 Feb 02;15:56
pubmed: 26830467
J Infect Dis. 2019 May 24;219(12):1994-2004
pubmed: 30452670
Thromb Haemost. 2015 Nov;114(5):1038-48
pubmed: 26155776
Sci Transl Med. 2013 Nov 13;5(211):211ps18
pubmed: 24225942
Nat Med. 2004 Feb;10(2):143-5
pubmed: 14745442
J Immunol. 2013 Sep 1;191(5):2495-502
pubmed: 23894199
Am J Pathol. 1994 Nov;145(5):1057-69
pubmed: 7526692
mSphere. 2017 Jun 7;2(3):
pubmed: 28596990
N Engl J Med. 2015 Mar 19;372(12):1126-37
pubmed: 25785970
J Med Chem. 2008 Mar 13;51(5):1453-8
pubmed: 18260612
Crit Care Med. 2015 Oct;43(10):2094-103
pubmed: 26121070
Infect Immun. 2006 Jun;74(6):3262-70
pubmed: 16714553
Emerg Microbes Infect. 2018 Jun 6;7(1):106
pubmed: 29872039
Am J Trop Med Hyg. 1992 May;46(5):589-94
pubmed: 1599053
J Thromb Haemost. 2007 Jan;5(1):155-65
pubmed: 17002660
Elife. 2017 Jun 07;6:
pubmed: 28590246
Trans R Soc Trop Med Hyg. 2005 May;99(5):333-40
pubmed: 15780339
Blood. 1967 May;29(5):713-21
pubmed: 5337147
J Thromb Haemost. 2015 Sep;13(9):1653-64
pubmed: 26186686
Crit Care Med. 2019 Aug;47(8):e677-e684
pubmed: 31162199
Stroke. 1999 Mar;30(3):542-5
pubmed: 10066849
Cell Host Microbe. 2013 May 15;13(5):521-534
pubmed: 23684304
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
Blood. 2014 Feb 13;123(7):1098-101
pubmed: 24264231
Crit Care Med. 2016 May;44(5):e278-88
pubmed: 26588828
Clin Infect Dis. 2018 Sep 14;67(7):991-999
pubmed: 29538635
Nat Med. 2013 Feb;19(2):156-67
pubmed: 23389616
Front Cell Infect Microbiol. 2014 Aug 21;4:104
pubmed: 25191643
PLoS One. 2017 Mar 1;12(3):e0172718
pubmed: 28249043
Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
pubmed: 11103309
Blood. 2010 Jun 3;115(22):4559-68
pubmed: 20220119
PLoS One. 2017 Oct 18;12(10):e0186276
pubmed: 29045442
Am J Respir Crit Care Med. 2013 Jan 15;187(2):160-9
pubmed: 23220920
Am J Trop Med Hyg. 1994 Aug;51(2):198-203
pubmed: 7521140
Blood. 2014 Jan 9;123(2):163-7
pubmed: 24246501
J Thromb Haemost. 2016 Nov;14(11):2274-2286
pubmed: 27589692
Blood. 1986 Feb;67(2):362-5
pubmed: 3002524
World Health Organ Tech Rep Ser. 2000;892:i-v, 1-74
pubmed: 10892307
Elife. 2018 Mar 26;7:
pubmed: 29578406
JAMA. 2016 Feb 23;315(8):817-9
pubmed: 26903341
J Biol Chem. 1998 Apr 10;273(15):8932-9
pubmed: 9535876
Int J Cardiol. 2016 Jun;212 Suppl 1:S14-21
pubmed: 27264866
Blood. 2011 Sep 29;118(13):3708-14
pubmed: 21700775
Ann Trop Med Parasitol. 1993 Dec;87(6):617-26
pubmed: 8122925
J Infect Dis. 2006 Jul 15;194(2):208-5
pubmed: 16779727
J Infect Dis. 2012 Aug 1;206(3):309-18
pubmed: 22634877
Cell Host Microbe. 2017 Nov 8;22(5):601-614.e5
pubmed: 29107642
Blood. 2013 Aug 1;122(5):842-51
pubmed: 23741007
Nature. 2019 May;569(7755):236-240
pubmed: 31043745
Am J Pathol. 2011 May;178(5):2146-58
pubmed: 21514429
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28893781
PLoS One. 2017 May 5;12(5):e0177142
pubmed: 28475625
Sci Immunol. 2019 Oct 18;4(40):
pubmed: 31628160
Circulation. 1997 Nov 18;96(10):3633-40
pubmed: 9396465
Thromb Haemost. 2016 Apr;115(4):773-80
pubmed: 26766771
Annu Rev Pathol. 2007;2:217-49
pubmed: 18039099
Biochem Soc Trans. 2008 Apr;36(Pt 2):221-8
pubmed: 18363564
Paediatr Indones. 1991 Jan-Feb;31(1-2):59-66
pubmed: 1852471
Blood. 2011 Aug 18;118(7):1952-61
pubmed: 21673343
Nature. 2013 Jun 27;498(7455):502-5
pubmed: 23739325
J Infect Dis. 2015 Jun 15;211(12):1977-86
pubmed: 25351204
PLoS One. 2017 Dec 15;12(12):e0188754
pubmed: 29244851

Auteurs

Christopher A Moxon (CA)

Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity, and Inflammation, College of Medical Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Malawi-Liverpool-Wellcome Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; and.

Yasir Alhamdi (Y)

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.

Janet Storm (J)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Julien M H Toh (JMH)

University of Sheffield Medical School, Sheffield, United Kingdom.

Dagmara McGuinness (D)

Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity, and Inflammation, College of Medical Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Joo Yeon Ko (JY)

Department of Dermatology, Hanyang University Hospital and Hanyang University College of Medicine, Seoul, South Korea.

George Murphy (G)

Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Steven Lane (S)

Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.

Terrie E Taylor (TE)

Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, MI.
Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi.

Karl B Seydel (KB)

Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, MI.
Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi.

Sam Kampondeni (S)

Queen Elizabeth Central Hospital, University of Malawi College of Medicine, Blantyre, Malawi.

Michael Potchen (M)

Department of Radiology, University of Rochester, Rochester, NY.

James S O'Donnell (JS)

Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Niamh O'Regan (N)

Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Guozheng Wang (G)

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.

Guillermo García-Cardeña (G)

Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Malcolm Molyneux (M)

Malawi-Liverpool-Wellcome Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; and.
Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Alister G Craig (AG)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Simon T Abrams (ST)

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.

Cheng-Hock Toh (CH)

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Roald Dahl Haemostasis & Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH